Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...

With 14 drugs posting double-digit sales growth in the most recent quarter, a promising obesity drug in late-stage trials, ...

Amgen's Imdelltra reduced the risk of death by 40% compared to chemotherapy for small cell lung cancer patients whose disease ...

Amgen's Nplate, which treats low blood platelet counts caused by an autoimmune condition, was highly effective at preventing ...

Amidst a (r)evolution in pharmaceutical strategy, Real World Evidence is more than ever a key driver of growing innovation in product life cycle. Leading organizations are rethinking their RWE ...

The smart inhalers market is experiencing significant growth, driven by the increasing incidence of respiratory diseases like asthma and COPD, techno ...

Here’s a look at who’s new. CRN’s 2024 Solution Provider 500 list ranks the top VARs, systems integrators, service providers and IT consultants with operations in North America by revenue.

Lupkynis (voclosporin) has been cleared by the European Commission for use in combination with immunosuppressant ... from the UK Medicines and Healthcare products Regulatory Agency (MHRA) in ...